Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, COVID-19, Decreased appetite, Dysphonia, Exposure to SARS-CoV-2
Clinical narrative: Felt like throat felt somewhat swollen; could not eat/do not have an appetite; Very uncomfortable from throat; Very uncomfortable from throat and above stomach; pain; raspy voice; Patient was exposed by COVID-19; Patient was exposed by COVID-19; She appeared on vaccination site for day 50 after her first injection; This spontaneous case was reported by a nurse and describes the occurrence of PHARYNGEAL SWELLING (Felt like throat felt somewhat swollen), DECREASED APPETITE (could not eat/do not have an appetite), OROPHARYNGEAL DISCOMFORT (Very uncomfortable from throat), ABDOMINAL DISCOMFORT (Very uncomfortable from throat and above stomach) and PAIN (pain) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Morphine) and Allergy to vaccine (Moderna Vaccine). Concomitant products included SIMVASTATIN for Cholesterol, LEVOTHYROXINE for Thyroid therapy, IRBESARTAN and HYDROCHLOROTHIAZIDE for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PHARYNGEAL SWELLING (Felt like throat felt somewhat swollen), DECREASED APPETITE (could not eat/do not have an appetite), OROPHARYNGEAL DISCOMFORT (Very uncomfortable from throat), ABDOMINAL DISCOMFORT (Very uncomfortable from throat and above stomach), PAIN (pain), DYSPHONIA (raspy voice), COVID-19 (Patient was exposed by COVID-19), EXPOSURE TO SARS-COV-2 (Patient was exposed by COVID-19) and PRODUCT DOSE OMISSION ISSUE (She appeared on vaccination site for day 50 after her first injection). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Allergic reaction, at a dose of 1 dosage form and FAMOTIDINE (PEPCID [FAMOTIDINE]) for Pain and Indigestion, at a dose of 1 dosage form. At the time of the report, PHARYNGEAL SWELLING (Felt like throat felt somewhat swollen), OROPHARYNGEAL DISCOMFORT (Very uncomfortable from throat), ABDOMINAL DISCOMFORT (Very uncomfortable from throat and above stomach), PAIN (pain), DYSPHONIA (raspy voice), COVID-19 (Patient was exposed by COVID-19) and EXPOSURE TO SARS-COV-2 (Patient was exposed by COVID-19) outcome was unknown, DECREASED APPETITE (could not eat/do not have an appetite) was resolving and PRODUCT DOSE OMISSION ISSUE (She appeared on vaccination site for day 50 after her first injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications included cough drops for raspy voice.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Follow-up information received on 02-JUN-2021: Patient contact information updated. Added patient initials. On 22-Jul-2021: Significant follow up received and Added the medical history(Allergy - Morphine, Moderna). Added  concomitant medications(Levothyrozine, simvastatom, Irbesartan, Hydrochlorot).Added the event -Pharyngeal Swelling, Decreased Appetite, Oropharyngeal discomfort, Abdominal discomfort, Pain, Dysphonia. Updated the start date of the drug from 03-FEB-2021 to 08-MAR-2021.